152 related articles for article (PubMed ID: 31377446)
1. In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database.
Azminah A; Erlina L; Radji M; Mun'im A; Syahdi RR; Yanuar A
Comput Biol Chem; 2019 Dec; 83():107096. PubMed ID: 31377446
[TBL] [Abstract][Full Text] [Related]
2. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
3. In Silico Design of Novel Sirtuin 1 Enzyme Activators for the Treatment of Age-related Diseases and Life Span.
Ertan-Bolelli T; Bolelli K
Curr Comput Aided Drug Des; 2021; 17(3):412-420. PubMed ID: 32321406
[TBL] [Abstract][Full Text] [Related]
4. Screening SIRT1 Activators from Medicinal Plants as Bioactive Compounds against Oxidative Damage in Mitochondrial Function.
Wang Y; Liang X; Chen Y; Zhao X
Oxid Med Cell Longev; 2016; 2016():4206392. PubMed ID: 26981165
[TBL] [Abstract][Full Text] [Related]
5. Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human aromatase inhibitors.
Dawood HM; Ibrahim RS; Shawky E; Hammoda HM; Metwally AM
J Ethnopharmacol; 2018 Oct; 224():359-372. PubMed ID: 29909120
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of Indonesian herbal compounds as COVID-19 supportive therapy: machine learning and pharmacophore modeling approaches.
Erlina L; Paramita RI; Kusuma WA; Fadilah F; Tedjo A; Pratomo IP; Ramadhanti NS; Nasution AK; Surado FK; Fitriawan A; Istiadi KA; Yanuar A
BMC Complement Med Ther; 2022 Aug; 22(1):207. PubMed ID: 35922786
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
8. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
[TBL] [Abstract][Full Text] [Related]
9. In silico evaluation of geroprotective phytochemicals as potential sirtuin 1 interactors.
Medoro A; Jafar TH; Ali S; Trung TT; Sorrenti V; Intrieri M; Scapagnini G; Davinelli S
Biomed Pharmacother; 2023 May; 161():114425. PubMed ID: 36812712
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease.
Kumar R; Nigam L; Singh AP; Singh K; Subbarao N; Dey S
Eur J Med Chem; 2017 Feb; 127():909-916. PubMed ID: 27836195
[TBL] [Abstract][Full Text] [Related]
11. Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
Naeem S; Hylands P; Barlow D
Bioorg Med Chem; 2012 Feb; 20(3):1251-8. PubMed ID: 22261024
[TBL] [Abstract][Full Text] [Related]
12. Assessing the performance of three resveratrol in binding with SIRT1 by molecular dynamics simulation and MM/GBSA methods: the weakest binding of resveratrol 3 to SIRT1 triggers a possibility of dissociation from its binding site.
Chen H; Wang Y; Gao Z; Yang W; Gao J
J Comput Aided Mol Des; 2019 Apr; 33(4):437-446. PubMed ID: 30805760
[TBL] [Abstract][Full Text] [Related]
13. Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.
Sun Y; Zhou H; Zhu H; Leung SW
Sci Rep; 2016 Jan; 6():19312. PubMed ID: 26805727
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel SIRT1 activators endowed with cardioprotective profile.
Flori L; Petrarolo G; Brogi S; La Motta C; Testai L; Calderone V
Eur J Pharm Sci; 2021 Oct; 165():105930. PubMed ID: 34265406
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 contributes to aldose reductase expression through modulating NFAT5 under osmotic stress: In vitro and in silico insights.
Timucin AC; Bodur C; Basaga H
Cell Signal; 2015 Nov; 27(11):2160-72. PubMed ID: 26297866
[TBL] [Abstract][Full Text] [Related]
16. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.
Manna D; Bhuyan R; Ghosh R
J Mol Model; 2018 Nov; 24(12):340. PubMed ID: 30448921
[TBL] [Abstract][Full Text] [Related]
17. Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence.
Scisciola L; Sarno F; Carafa V; Cosconati S; Di Maro S; Ciuffreda L; De Angelis A; Stiuso P; Feoli A; Sbardella G; Altucci L; Nebbioso A
Epigenetics; 2020; 15(6-7):664-683. PubMed ID: 31942817
[TBL] [Abstract][Full Text] [Related]
18. Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing.
Karaman B; Alhalabi Z; Swyter S; Mihigo SO; Andrae-Marobela K; Jung M; Sippl W; Ntie-Kang F
Molecules; 2018 Feb; 23(2):. PubMed ID: 29443909
[TBL] [Abstract][Full Text] [Related]
19. Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
Kim MJ; An HJ; Kim DH; Lee B; Lee HJ; Ullah S; Kim SJ; Jeong HO; Moon KM; Lee EK; Yang J; Akter J; Chun P; Moon HR; Chung HY
Bioorg Med Chem Lett; 2018 Feb; 28(4):684-688. PubMed ID: 29402742
[TBL] [Abstract][Full Text] [Related]
20. Mounting evidence validates Ursolic Acid directly activates SIRT1: A powerful STAC which mimic endogenous activator of SIRT1.
Bakhtiari N; Mirzaie S; Hemmati R; Moslemee-Jalalvand E; Noori AR; Kazemi J
Arch Biochem Biophys; 2018 Jul; 650():39-48. PubMed ID: 29758202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
